Drug Discovery

How Does ROXYBOND Fight Opioid Abuse and Ensure Pain Relief?
Research & Development How Does ROXYBOND Fight Opioid Abuse and Ensure Pain Relief?

The recent FDA approval of Protega Pharmaceuticals Inc.'s ROXYBOND (oxycodone hydrochloride) immediate-release (IR) CII 10 mg tablet marks a significant milestone in managing severe pain where alternative treatments fall short. ROXYBOND 10 mg stands out as the first FDA-approved

How Will Kapoose Creek Bio's New Acquisition Transform Drug Discovery?
Research & Development How Will Kapoose Creek Bio's New Acquisition Transform Drug Discovery?

Kapoose Creek Bio, a biotechnology firm well-versed in AI-driven natural product drug discovery, has made a significant leap forward with its latest acquisition. The company has secured an exclusive license to the chemical informatics platform of Adapsyn Bioscience and acquired Adapsyn's drug

The Impact of Artificial Intelligence on Drug Discovery
Tech & Innovation The Impact of Artificial Intelligence on Drug Discovery

Artificial Intelligence (AI) has emerged as a transformative force in numerous sectors, and nowhere is its impact more pronounced than in the field of drug discovery. This field, traditionally marked by high costs, time-consuming processes, and a significant amount of trial and error, is witnessing

Roche Ends UCB Partnership on Anti-Tau Alzheimer's Drug Bepranemab
Management & Regulatory Roche Ends UCB Partnership on Anti-Tau Alzheimer's Drug Bepranemab

Roche's recent decision to return the rights to UCB’s anti-tau antibody bepranemab comes after a four-year investment in the Alzheimer's disease drug candidate, which was initially valued at up to $2 billion in milestones. This strategic move happens just before the release of phase 2a d

AI Revolutionizes Early Drug Discovery with Precision and Efficiency
Research & Development AI Revolutionizes Early Drug Discovery with Precision and Efficiency

The modern biopharmaceutical industry is witnessing a significant transformation, thanks to the integration of artificial intelligence (AI) tools in early drug discovery. AI’s capabilities in managing and analyzing vast amounts of data generated from cell-based preclinical models through imaging a

How Does the Retrogenix Non-Human Protein Library Aid Drug Discovery?
Research & Development How Does the Retrogenix Non-Human Protein Library Aid Drug Discovery?

Charles River Laboratories has taken a significant stride in the realm of biopharmaceutical research by launching the Retrogenix Non-Human Protein Library. This innovation is particularly designed to help clients assess the off-target interactions of their therapeutics with non-human proteins. The

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later